ABBVIE (4AB BE) stock market data APIs
€197.073
-2.15(-1.1%)
as of October 30, 2025
Try our APIs with
free plan!
ABBVIE Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for 4AB.BE.
Prev. Close
197.073
Open
194.9202
High
198.7739
Low
193.0259
52 wk Range
144.6006-206.522
Market Cap
196 410 M
Dividends (Yield)
0.0457
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ABBVIE data using free add-ons & libraries
Get ABBVIE Fundamental Data
ABBVIE Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-31
- EPS/Forecast: 1.78
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ABBVIE News
New
ELAHERE® Receives Positive Reimbursement Recommendation by Canada's Drug Agency for Certain Types of Platinum-Resistant Ovarian Cancers
ELAHERE® receives a positive recommendation by Canada's Drug Agency (CDA-AMC) ELAHERE ® was submitted for reimbursement review 180 days prior to Health Canada's approval in line with CDA-AMC's new ...
Amazon, Apple Earnings, ECB Rate Decision: Still to Come This Week
Investors will tune into earnings from Amazon and Apple, plus the European Central Bank's interest-rate decision. Here’s what to watch for: Today Earnings: Amazon, Apple, Eli Lilly, Hershey, Masterc...
AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect
Pharmaceutical company AbbVie (NYSE:ABBV) will be reporting results this Friday before market open. Here’s what you need to know. AbbVie beat analysts’ revenue expectations by 2.6% last quarter, ...
Assessing AbbVie’s Value After 25.5% Rally and Oncology Growth Moves in 2025
If you own AbbVie stock or are thinking about adding it to your portfolio, you’ve probably noticed the ups and downs lately. After an impressive 25.5% gain so far this year, shares have cooled off a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
